Qualified from the University of Leicester in 1991. He trained in Leicester, Southampton and Portsmouth and was involved in the early development of EVAR within the UK, work that led to his MD thesis. He undertook a year of endovascular training at the Royal Adelaide Hospital prior to his appointment as Consultant Vascular Surgeon at Addenbrooke’s Hospital, Cambridge in 2002. 

 

He has active research interests in EVAR, outcome modelling and renal injury in vascular surgery, publishing extensively on these topics. He established an endovascular service for ruptured aneurysms in Cambridge. 

 

He is the current President of the Vascular Society of Great Britain and Ireland (2021-2022) and served as British Society of Endovascular Therapy President from 2013-2015. He is Senior Editor elect of European Journal of Vascular and Endovascular Surgery and also a long-standing member of the Editorial Board of the Journal of Endovascular Therapy.

 

Furthermore he is enthusiastic about post-graduate training, he served as Training Programme Director for Core Surgical Training in the East of England from 2007-2012 and Chairman of the Vascular Specialty Advisory Committee (SAC) overseeing vascular training in the UK and Ireland from 2015-2018. He is an Affiliate Associate Professor in the Department of Surgery at the University of Cambridge.

 

He is the immediate past Chair of the Audit and QI Committee of the Vascular Society and was the driving force behind the Peripheral Arterial Disease Quality Improvement Framework (PAD-QIF) and collection of aortic device data within the National Vascular Registry. This work has led to his recent appointment as Chair of the Vascular Surgery and Interventional Radiology Steering Group for the NHS Medical Devices Safety Programme.

Professor Andrew Bradbury took up post as the Sampson Gamgee Professor of Vascular Surgery at the University of Birmingham (UoB), and as an Honorary Consultant Vascular Surgeon at the Heart of England (now University Hospitals Birmingham) NHS Foundation Trust, in January 2000, having previously worked as a Senior Lecturer and Consultant Surgeon at the University of Edinburgh since 1995, following training in General and Vascular Surgery in Scotland and London.

From 2005 to 2010, Andrew was the Education Dean responsible for running the MB ChB and all the other clinical programmes within the College of Medical and Dental Sciences at UoB. During that period, Andrew completed an MBA at the Birmingham Business School at UoB.

Between 2015 and 2022, Andrew was Chair of the UK National Institute of Health Research (NIHR) Health Technology Assessment (HTA) research programme Hospital-based Care Committee, and was also a member of the NIHR HTA Programme Oversight Committee, reporting to the Director. 

Andrew co-authored the UK National Institute for Health and Care Excellence (NICE) national guidelines on Peripheral Arterial Disease (PAD) (2012) and on Varicose Veins and Leg Ulcers (2013), and also chaired the NICE Abdominal Aortic Aneurysm (AAA) national Guideline Committee (GC) (2015-2020).

Andrew has published over 250 articles in peer review journals and authored numerous book chapters. Recent publication highlights include the UK NIHR HTA funded EndoVenous Reflux Ablation (EVRA) trial results in the NEJM (2018), the Global Vascular Guidelines (GVG) on Chronic Limb Threatening Ischaemia (CLTI) in the JVS and EJVES (2019), and UK NIHR HTA funded Graduated compression stockings as an Adjuvant to Pharmaco-prophylaxis in elective Surgical patients (GAPS) trial in the BMJ (2020).

Andrew is Chief Investigator and grant-holder for the UK NIHR HTA funded BASIL-1, 2 and 3 trials. The BASIL-2 results were published in The Lancet in April 2023. Andrew expects to be able to publish the BASIL-3 results in a high impact journal towards the end of 2023.

Andrew retired from National Health Service (NHS) and private clinical practice at the end of 2022 but is still working part-time for the UoB in order to complete the BASIL-2 and -3 trials, and to see through various other academic commitments. Andrew has been awarded Emeritus Professor status by the UoB from the end of 2024.

Dr Dias is currently a Senior Consultant and Professor at the Vascular Center in Malmö and Lund University in Sweden. He defended his PhD thesis on endovascular aortic repair and direct intra-aneurysm pressure measurements in 2004. Dr Dias has published numerous peer reviewed articles and book chapters on vascular and endovascular surgery, particularly regarding aortic diseases.  He is currently the head of the Endovascular Section at the Vascular Center in Malmö, a member of the Editorial Board of the European Journal of Vascular and Endovascular Surgery and of the Guidelines Committee, and the Scientific Secretary of the Swedish Vascular Society.

 

Dr Austermann is the Director at the Institute for Vascular Research at St. Franziskus Hospital Münster.